サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：経腸栄養製剤の世界市場：成長、将来展望、競合分析 (2024年～2032年)
市場調査レポート
商品コード
1642609

経腸栄養製剤の世界市場：成長、将来展望、競合分析 (2024年～2032年)

Enteral Feeding Formulas Market - Growth, Future Prospects and Competitive Analysis, 2024 - 2032

出版日
ページ情報
英文 180 Pages
納期
即日から翌営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
経腸栄養製剤の世界市場：成長、将来展望、競合分析 (2024年～2032年)
出版日: 2024年11月15日
発行: Acute Market Reports
ページ情報: 英文 180 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

経腸栄養製剤市場には、経口摂取が不十分、不可能、または安全でない場合に、消化管を通じて患者に投与される様々な栄養ソリューションが含まれます。この栄養補給方法は、病院、長期介護施設、在宅介護など、さまざまなヘルスケア環境で使用されています。経腸栄養は、特に慢性疾患を患っている患者、手術を受けている患者、栄養不良の問題を抱えている患者にとって、臨床栄養の重要な要素です。こうした経腸栄養剤の市場を牽引しているのは、慢性疾患の有病率の上昇、配合組成の進歩、世界の高齢者人口の増加です。経腸栄養製剤市場は、2024年から2032年の予測期間中にCAGR 7.2％で成長すると予測されます。

経腸栄養製剤市場の促進要因

慢性疾患および栄養不良の発生率の上昇

がん、糖尿病、神経疾患など、患者が適切な経口摂取を維持することが困難な慢性疾患の有病率の増加は、経腸栄養製剤市場の主要促進要因です。これらのフォーミュラによって提供される強化された栄養は、病気の症状を管理し、回復をサポートし、患者の全体的な生活の質を向上させる。病院や長期介護施設では、栄養不良や病気に関連した消耗を管理するための標準的なケアとして経腸栄養を採用するケースが増えており、こうした製品の需要をさらに押し上げています。

フィーディング・フォーミュラおよび機器の技術的進歩

経腸栄養製品の処方および送達における大幅な技術進歩により、その使用と効率が拡大しています。腎不全や肺疾患のような特定の状態にある患者特有の栄養ニーズに対応する疾患特異的処方の開発により、患者の転帰と栄養療法のコンプライアンスが向上しています。正確で安全な栄養補給を可能にするプログラム可能なポンプなど、栄養補給システムにおける技術革新も市場の成長に寄与しています。こうした技術的強化により、摂食製剤の嗜好性、吸収性、有効性が改善され、さまざまな医療や在宅ケアの現場での採用が増加しています。

世界人口の高齢化

慢性疾患や嚥下障害（飲み込みにくさ）を抱えやすい高齢者人口の世界の増加が、経腸栄養製剤の需要を大きく押し上げています。高齢の患者は、健康を維持し、加齢に伴う生理的変化を管理するために、長期的な栄養管理を必要とすることが多いです。経腸栄養剤は、使いやすさと在宅での投与が可能であることから、高齢者ケアに適した選択肢となっており、この分野の市場の持続的成長を支えています。

経腸栄養製剤市場の抑制要因

経腸栄養に伴う合併症

経腸栄養製剤市場は、そのメリットにもかかわらず、経管栄養に伴う合併症が大きな抑制要因となっています。チューブの脱落、感染症、下痢や便秘のような消化管合併症などの問題は、経腸栄養の使用を妨げる可能性があります。これらの合併症は、注意深いモニタリングと管理を必要とし、全体的なヘルスケアコストと医療者および介護者の負担を増加させる。誤嚥やその結果生じる肺炎のリスクも、特に高齢者や重症の患者において、深刻な健康リスクをもたらします。この課題は、経腸栄養の利点と副作用の可能性とのバランスを取らなければならないヘルスケア提供者の経腸栄養導入率に影響を与えます。こうしたリスク管理の複雑さと、経管栄養技術に関する介護者やヘルスケア専門家の専門的トレーニングの必要性が相まって、市場の成長可能性はやや制限されています。

製品別市場セグメンテーション

経腸栄養製剤市場は、製品別に標準製剤、疾患特異的製剤、エレメンタル製剤、セミエレメンタル製剤、その他の製剤に区分されます。疾患特異的フォーミュラは、腎疾患、呼吸器疾患、糖尿病などの特定の臨床状態を管理するための的を絞ったアプローチのため、最も高い年間平均成長率（CAGR）を示すと予測されています。これらの処方は、これらの疾患特有の栄養要件や制限を満たすように設計されており、患者の転帰やコンプライアンスを向上させる。一方、市場で最も高い収益を上げると予想されるのは標準的な製剤です。これらの処方は、特定の食事制限や特殊な栄養ニーズを持たない患者にバランスの取れた栄養を提供する一般的な用途に広く使用されています。標準製剤は、病院から在宅ケアまで、さまざまなヘルスケア環境における経腸栄養の基本的な部分であり、経腸栄養業界の主力製品となっています。これらの製品が広く使用され、日常的な臨床ケアの一環として経腸栄養が受け入れられつつあることが、このセグメントの大幅な収益を牽引しています。

ステージ別市場セグメンテーション

経腸栄養製剤市場において、ステージ別のセグメンテーションには成人患者と小児患者が含まれます。小児用セグメントは、早期開発段階における適切な栄養摂取の重要な必要性、および発育不全、脳性麻痺、嚢胞性線維症などの経口摂取を損なう小児疾患や障害の発生率の上昇により、CAGRが最も高くなると予想されます。小児用ミルクは、小児の成長要件と代謝率を考慮し、小児の栄養ニーズを満たすよう特別に設計されています。対照的に、経腸栄養を必要とする成人患者の数が多いため、成人用セグメントは最も高い収益を占めています。これには、慢性疾患を持つ高齢患者や手術後の回復過程にある患者、障害を持つ成人や緩和ケアを受けている患者が含まれます。成人セグメントの売上高における優位性は、世界の高齢化人口の増加と長期的な栄養管理を必要とする慢性疾患の蔓延によって支えられており、成人特有の経腸栄養製剤に対する持続的な需要を確保しています。

経腸栄養製剤市場の地域セグメント

経腸栄養製剤市場の地理的動向では、北米が現在収益面でリードしており、これは高度なヘルスケアインフラ、高いヘルスケア支出、臨床栄養ソリューションを必要とする慢性疾患の有病率の増加が後押ししています。さらに、同地域の厳しい規制基準と経腸栄養の利点に関する高い認知度が市場の優位性を維持しています。一方、アジア太平洋は2024年から2032年にかけて最も高い年間平均成長率（CAGR）を示すと予想されています。この急成長は、特に日本や中国などの国々で高齢者人口が増加していることに加え、ヘルスケア支出の増加やヘルスケア・インフラの改善が背景にあります。これらの地域では、病院の拡大や栄養管理を必要とする疾患の有病率の増加も市場成長を加速させる重要な要因となっています。さらに、患者の予後改善を目指す政府の取り組みや在宅医療サービスの導入拡大が、アジア太平洋地域における経腸栄養ソリューションの需要を増大させており、世界情勢の中で急速に拡大する市場となっています。

経腸栄養製剤市場の競合動向

経腸栄養製剤市場の競合情勢には、Abbott Laboratories、B. Braun Melsungen AG、Baxter International、Danone S.A.、Fresenius Kabi、Functional Formularies、Hormel Health Labs、Kate Farms、Medtrition、Meiji Holdings、Nestle、NutriMedical、Real Food Blends、Vegenat Healthcare、Victusといった有力企業が名を連ねています。これらの企業は、継続的なイノベーションと戦略的イニシアティブを通じて市場力学の形成に貢献してきました。2022年には、ネスレやアボット・ラボラトリーズのような主要企業が、多様な製品ポートフォリオと強力な世界流通網を背景に堅調な収益を計上しました。2024年から2032年にかけて、これらの主要企業は地理的プレゼンスを拡大し、多様な患者集団の特定の栄養ニーズを満たすための製品提供を強化することに注力すると予想されます。各社は自社の能力を拡大し、新興市場への参入を目指すため、戦略的な合併・買収が盛んになると予想されます。さらに、さまざまな病状に対応する、より専門的で疾患特異的な処方の開発に重点を置いた研究開発への投資も増加すると予想されます。また、よりクリーンで透明性の高い成分表を求める消費者の需要に応え、オーガニックや非遺伝子組み換えの処方の開発も牽引力を増すと予想されます。さらに、ヘルスケア・プロバイダーや医療機関との提携により、先進的な栄養ソリューションの普及と実施が強化され、イノベーションと規制遵守の両方が求められる市場で、各社が競争力を維持できるようになると思われます。これらの戦略により、経腸栄養製剤市場のトップ企業は、患者の転帰の向上と世界展開の拡大を通じて市場成長を促進しながら、優位性を維持し続けることになるであろう。

目次

第1章 序文

  • 分析内容
    • 分析の目的
    • 対象者
    • 主な提供内容
  • 市場セグメンテーション
  • 分析手法
    • フェーズⅠ：二次調査
    • フェーズⅡ：一次調査
    • フェーズⅢ：有識者レビュー
    • 前提条件
    • 採用したアプローチ

第2章 エグゼクティブサマリー

第3章 経腸栄養製剤市場：競合分析

  • 主要ベンダーの市場ポジショニング
  • ベンダーが採用した戦略
  • 主要な産業戦略

第4章 経腸栄養製剤市場：マクロ分析と市場力学

  • イントロダクション
  • 世界の経腸栄養製剤市場 (金額ベース、2022～2032年)
  • 市場力学
    • 市場促進要因
    • 市場抑制要因
    • 主な課題
    • 主な機会
  • 促進要因と抑制要因の影響分析
  • シーソー分析
  • ポーターのファイブフォースモデル
    • サプライヤーパワー
    • バイヤーパワー
    • 代替品の脅威
    • 新規参入業者の脅威
    • 競争企業間の敵対関係
  • PESTEL分析
    • 政治的情勢
    • 経済的情勢
    • 技術的情勢
    • 法的情勢
    • 社会的情勢

第5章 経腸栄養製剤市場：製品別 (2022～2032年)

  • 市場概要
  • 成長・収益分析：2023年 vs 2032年
  • 市場セグメンテーション
    • 標準式
    • 疾患別の処方
    • 元素式
    • 半元素式
    • その他の式

第6章 経腸栄養製剤市場：ステージ別 (2022～2032年)

  • 市場概要
  • 成長・収益分析：2023年 vs 2032年
  • 市場セグメンテーション
    • 成人
    • 小児

第7章 経腸栄養製剤市場：用途別 (2022～2032年)

  • 市場概要
  • 成長・収益分析：2023年 vs 2032年
  • 市場セグメンテーション
    • 腫瘍学
    • 消化器疾患
    • 神経疾患
    • 糖尿病
    • 集中治療
    • その他の用途

第8章 経腸栄養製剤市場：最終用途別 (2022～2032年)

  • 市場概要
  • 成長・収益分析：2023年 vs 2032年
  • 市場セグメンテーション
    • 病院
    • 長期介護施設
    • 在宅医療
    • 老人ホーム

第9章 北米の経腸栄養製剤市場 (2022～2032年)

  • 市場概要
  • 経腸栄養製剤市場：製品別 (2022～2032年)
  • 経腸栄養製剤市場：ステージ別 (2022～2032年)
  • 経腸栄養製剤市場：用途別 (2022～2032年)
  • 経腸栄養製剤市場：最終用途別 (2022～2032年)
  • 経腸栄養製剤市場：地域別 (2022～2032年)
    • 北米
      • 米国
      • カナダ
      • その他北米地域

第10章 英国・EU諸国の経腸栄養製剤市場 (2022～2032年)

  • 市場概要
  • 経腸栄養製剤市場：製品別 (2022～2032年)
  • 経腸栄養製剤市場：ステージ別 (2022～2032年)
  • 経腸栄養製剤市場：用途別 (2022～2032年)
  • 経腸栄養製剤市場：最終用途別 (2022～2032年)
  • 経腸栄養製剤市場：地域別 (2022～2032年)
    • 英国・EU諸国
      • 英国
      • ドイツ
      • スペイン
      • イタリア
      • フランス
      • その他欧州地域

第11章 アジア太平洋の経腸栄養製剤市場 (2022～2032年)

  • 市場概要
  • 経腸栄養製剤市場：製品別 (2022～2032年)
  • 経腸栄養製剤市場：ステージ別 (2022～2032年)
  • 経腸栄養製剤市場：用途別 (2022～2032年)
  • 経腸栄養製剤市場：最終用途別 (2022～2032年)
  • 経腸栄養製剤市場：地域別 (2022～2032年)
    • アジア太平洋地域
      • 中国
      • 日本
      • インド
      • オーストラリア
      • 韓国
      • その他アジア太平洋地域

第12章 ラテンアメリカの経腸栄養製剤市場 (2022～2032年)

  • 市場概要
  • 経腸栄養製剤市場：製品別 (2022～2032年)
  • 経腸栄養製剤市場：ステージ別 (2022～2032年)
  • 経腸栄養製剤市場：用途別 (2022～2032年)
  • 経腸栄養製剤市場：最終用途別 (2022～2032年)
  • 経腸栄養製剤市場：地域別 (2022～2032年)
    • ラテンアメリカ
      • ブラジル
      • メキシコ
      • その他ラテンアメリカ地域

第13章 中東・アフリカの経腸栄養製剤市場 (2022～2032年)

  • 市場概要
  • 経腸栄養製剤市場：製品別 (2022～2032年)
  • 経腸栄養製剤市場：ステージ別 (2022～2032年)
  • 経腸栄養製剤市場：用途別 (2022～2032年)
  • 経腸栄養製剤市場：最終用途別 (2022～2032年)
  • 経腸栄養製剤市場：地域別 (2022～2032年)
    • 中東・アフリカ
      • GCC
      • アフリカ
      • その他中東・アフリカ地域

第14章 企業プロファイル

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Baxter International
  • Danone S.A.
  • Fresenius Kabi
  • Functional Formularies
  • Hormel Health Labs
  • Kate Farms
  • Medtrition
  • Meiji Holdings
  • Nestle
  • NutriMedical
  • Real Food Blends
  • Vegenat Healthcare
  • Victus
図表

List of Tables

  • TABLE 1 Global Enteral Feeding Formulas Market By Product, 2022-2032, USD (Million)
  • TABLE 2 Global Enteral Feeding Formulas Market By Stage, 2022-2032, USD (Million)
  • TABLE 3 Global Enteral Feeding Formulas Market By Application, 2022-2032, USD (Million)
  • TABLE 4 Global Enteral Feeding Formulas Market By End Use, 2022-2032, USD (Million)
  • TABLE 5 North America Enteral Feeding Formulas Market By Product, 2022-2032, USD (Million)
  • TABLE 6 North America Enteral Feeding Formulas Market By Stage, 2022-2032, USD (Million)
  • TABLE 7 North America Enteral Feeding Formulas Market By Application, 2022-2032, USD (Million)
  • TABLE 8 North America Enteral Feeding Formulas Market By End Use, 2022-2032, USD (Million)
  • TABLE 9 U.S. Enteral Feeding Formulas Market By Product, 2022-2032, USD (Million)
  • TABLE 10 U.S. Enteral Feeding Formulas Market By Stage, 2022-2032, USD (Million)
  • TABLE 11 U.S. Enteral Feeding Formulas Market By Application, 2022-2032, USD (Million)
  • TABLE 12 U.S. Enteral Feeding Formulas Market By End Use, 2022-2032, USD (Million)
  • TABLE 13 Canada Enteral Feeding Formulas Market By Product, 2022-2032, USD (Million)
  • TABLE 14 Canada Enteral Feeding Formulas Market By Stage, 2022-2032, USD (Million)
  • TABLE 15 Canada Enteral Feeding Formulas Market By Application, 2022-2032, USD (Million)
  • TABLE 16 Canada Enteral Feeding Formulas Market By End Use, 2022-2032, USD (Million)
  • TABLE 17 Rest of North America Enteral Feeding Formulas Market By Product, 2022-2032, USD (Million)
  • TABLE 18 Rest of North America Enteral Feeding Formulas Market By Stage, 2022-2032, USD (Million)
  • TABLE 19 Rest of North America Enteral Feeding Formulas Market By Application, 2022-2032, USD (Million)
  • TABLE 20 Rest of North America Enteral Feeding Formulas Market By End Use, 2022-2032, USD (Million)
  • TABLE 21 UK and European Union Enteral Feeding Formulas Market By Product, 2022-2032, USD (Million)
  • TABLE 22 UK and European Union Enteral Feeding Formulas Market By Stage, 2022-2032, USD (Million)
  • TABLE 23 UK and European Union Enteral Feeding Formulas Market By Application, 2022-2032, USD (Million)
  • TABLE 24 UK and European Union Enteral Feeding Formulas Market By End Use, 2022-2032, USD (Million)
  • TABLE 25 UK Enteral Feeding Formulas Market By Product, 2022-2032, USD (Million)
  • TABLE 26 UK Enteral Feeding Formulas Market By Stage, 2022-2032, USD (Million)
  • TABLE 27 UK Enteral Feeding Formulas Market By Application, 2022-2032, USD (Million)
  • TABLE 28 UK Enteral Feeding Formulas Market By End Use, 2022-2032, USD (Million)
  • TABLE 29 Germany Enteral Feeding Formulas Market By Product, 2022-2032, USD (Million)
  • TABLE 30 Germany Enteral Feeding Formulas Market By Stage, 2022-2032, USD (Million)
  • TABLE 31 Germany Enteral Feeding Formulas Market By Application, 2022-2032, USD (Million)
  • TABLE 32 Germany Enteral Feeding Formulas Market By End Use, 2022-2032, USD (Million)
  • TABLE 33 Spain Enteral Feeding Formulas Market By Product, 2022-2032, USD (Million)
  • TABLE 34 Spain Enteral Feeding Formulas Market By Stage, 2022-2032, USD (Million)
  • TABLE 35 Spain Enteral Feeding Formulas Market By Application, 2022-2032, USD (Million)
  • TABLE 36 Spain Enteral Feeding Formulas Market By End Use, 2022-2032, USD (Million)
  • TABLE 37 Italy Enteral Feeding Formulas Market By Product, 2022-2032, USD (Million)
  • TABLE 38 Italy Enteral Feeding Formulas Market By Stage, 2022-2032, USD (Million)
  • TABLE 39 Italy Enteral Feeding Formulas Market By Application, 2022-2032, USD (Million)
  • TABLE 40 Italy Enteral Feeding Formulas Market By End Use, 2022-2032, USD (Million)
  • TABLE 41 France Enteral Feeding Formulas Market By Product, 2022-2032, USD (Million)
  • TABLE 42 France Enteral Feeding Formulas Market By Stage, 2022-2032, USD (Million)
  • TABLE 43 France Enteral Feeding Formulas Market By Application, 2022-2032, USD (Million)
  • TABLE 44 France Enteral Feeding Formulas Market By End Use, 2022-2032, USD (Million)
  • TABLE 45 Rest of Europe Enteral Feeding Formulas Market By Product, 2022-2032, USD (Million)
  • TABLE 46 Rest of Europe Enteral Feeding Formulas Market By Stage, 2022-2032, USD (Million)
  • TABLE 47 Rest of Europe Enteral Feeding Formulas Market By Application, 2022-2032, USD (Million)
  • TABLE 48 Rest of Europe Enteral Feeding Formulas Market By End Use, 2022-2032, USD (Million)
  • TABLE 49 Asia Enteral Feeding Formulas Market By Product, 2022-2032, USD (Million)
  • TABLE 50 Asia Enteral Feeding Formulas Market By Stage, 2022-2032, USD (Million)
  • TABLE 51 Asia Enteral Feeding Formulas Market By Application, 2022-2032, USD (Million)
  • TABLE 52 Asia Enteral Feeding Formulas Market By End Use, 2022-2032, USD (Million)
  • TABLE 53 China Enteral Feeding Formulas Market By Product, 2022-2032, USD (Million)
  • TABLE 54 China Enteral Feeding Formulas Market By Stage, 2022-2032, USD (Million)
  • TABLE 55 China Enteral Feeding Formulas Market By Application, 2022-2032, USD (Million)
  • TABLE 56 China Enteral Feeding Formulas Market By End Use, 2022-2032, USD (Million)
  • TABLE 57 Japan Enteral Feeding Formulas Market By Product, 2022-2032, USD (Million)
  • TABLE 58 Japan Enteral Feeding Formulas Market By Stage, 2022-2032, USD (Million)
  • TABLE 59 Japan Enteral Feeding Formulas Market By Application, 2022-2032, USD (Million)
  • TABLE 60 Japan Enteral Feeding Formulas Market By End Use, 2022-2032, USD (Million)
  • TABLE 61 India Enteral Feeding Formulas Market By Product, 2022-2032, USD (Million)
  • TABLE 62 India Enteral Feeding Formulas Market By Stage, 2022-2032, USD (Million)
  • TABLE 63 India Enteral Feeding Formulas Market By Application, 2022-2032, USD (Million)
  • TABLE 64 India Enteral Feeding Formulas Market By End Use, 2022-2032, USD (Million)
  • TABLE 65 Australia Enteral Feeding Formulas Market By Product, 2022-2032, USD (Million)
  • TABLE 66 Australia Enteral Feeding Formulas Market By Stage, 2022-2032, USD (Million)
  • TABLE 67 Australia Enteral Feeding Formulas Market By Application, 2022-2032, USD (Million)
  • TABLE 68 Australia Enteral Feeding Formulas Market By End Use, 2022-2032, USD (Million)
  • TABLE 69 South Korea Enteral Feeding Formulas Market By Product, 2022-2032, USD (Million)
  • TABLE 70 South Korea Enteral Feeding Formulas Market By Stage, 2022-2032, USD (Million)
  • TABLE 71 South Korea Enteral Feeding Formulas Market By Application, 2022-2032, USD (Million)
  • TABLE 72 South Korea Enteral Feeding Formulas Market By End Use, 2022-2032, USD (Million)
  • TABLE 73 Latin America Enteral Feeding Formulas Market By Product, 2022-2032, USD (Million)
  • TABLE 74 Latin America Enteral Feeding Formulas Market By Stage, 2022-2032, USD (Million)
  • TABLE 75 Latin America Enteral Feeding Formulas Market By Application, 2022-2032, USD (Million)
  • TABLE 76 Latin America Enteral Feeding Formulas Market By End Use, 2022-2032, USD (Million)
  • TABLE 77 Brazil Enteral Feeding Formulas Market By Product, 2022-2032, USD (Million)
  • TABLE 78 Brazil Enteral Feeding Formulas Market By Stage, 2022-2032, USD (Million)
  • TABLE 79 Brazil Enteral Feeding Formulas Market By Application, 2022-2032, USD (Million)
  • TABLE 80 Brazil Enteral Feeding Formulas Market By End Use, 2022-2032, USD (Million)
  • TABLE 81 Mexico Enteral Feeding Formulas Market By Product, 2022-2032, USD (Million)
  • TABLE 82 Mexico Enteral Feeding Formulas Market By Stage, 2022-2032, USD (Million)
  • TABLE 83 Mexico Enteral Feeding Formulas Market By Application, 2022-2032, USD (Million)
  • TABLE 84 Mexico Enteral Feeding Formulas Market By End Use, 2022-2032, USD (Million)
  • TABLE 85 Rest of Latin America Enteral Feeding Formulas Market By Product, 2022-2032, USD (Million)
  • TABLE 86 Rest of Latin America Enteral Feeding Formulas Market By Stage, 2022-2032, USD (Million)
  • TABLE 87 Rest of Latin America Enteral Feeding Formulas Market By Application, 2022-2032, USD (Million)
  • TABLE 88 Rest of Latin America Enteral Feeding Formulas Market By End Use, 2022-2032, USD (Million)
  • TABLE 89 Middle East and Africa Enteral Feeding Formulas Market By Product, 2022-2032, USD (Million)
  • TABLE 90 Middle East and Africa Enteral Feeding Formulas Market By Stage, 2022-2032, USD (Million)
  • TABLE 91 Middle East and Africa Enteral Feeding Formulas Market By Application, 2022-2032, USD (Million)
  • TABLE 92 Middle East and Africa Enteral Feeding Formulas Market By End Use, 2022-2032, USD (Million)
  • TABLE 93 GCC Enteral Feeding Formulas Market By Product, 2022-2032, USD (Million)
  • TABLE 94 GCC Enteral Feeding Formulas Market By Stage, 2022-2032, USD (Million)
  • TABLE 95 GCC Enteral Feeding Formulas Market By Application, 2022-2032, USD (Million)
  • TABLE 96 GCC Enteral Feeding Formulas Market By End Use, 2022-2032, USD (Million)
  • TABLE 97 Africa Enteral Feeding Formulas Market By Product, 2022-2032, USD (Million)
  • TABLE 98 Africa Enteral Feeding Formulas Market By Stage, 2022-2032, USD (Million)
  • TABLE 99 Africa Enteral Feeding Formulas Market By Application, 2022-2032, USD (Million)
  • TABLE 100 Africa Enteral Feeding Formulas Market By End Use, 2022-2032, USD (Million)
  • TABLE 101 Rest of Middle East and Africa Enteral Feeding Formulas Market By Product, 2022-2032, USD (Million)
  • TABLE 102 Rest of Middle East and Africa Enteral Feeding Formulas Market By Stage, 2022-2032, USD (Million)
  • TABLE 103 Rest of Middle East and Africa Enteral Feeding Formulas Market By Application, 2022-2032, USD (Million)
  • TABLE 104 Rest of Middle East and Africa Enteral Feeding Formulas Market By End Use, 2022-2032, USD (Million)

List of Figures

  • FIG. 1 Global Enteral Feeding Formulas Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Enteral Feeding Formulas Market: Quality Assurance
  • FIG. 5 Global Enteral Feeding Formulas Market, By Product, 2023
  • FIG. 6 Global Enteral Feeding Formulas Market, By Stage, 2023
  • FIG. 7 Global Enteral Feeding Formulas Market, By Application, 2023
  • FIG. 8 Global Enteral Feeding Formulas Market, By End Use, 2023
  • FIG. 9 Global Enteral Feeding Formulas Market, By Geography, 2023
  • FIG. 10 Market Geographical Opportunity Matrix - Global Enteral Feeding Formulas Market, 2023
  • FIG. 11Market Positioning of Key Enteral Feeding Formulas Market Players, 2023
  • FIG. 12Global Enteral Feeding Formulas Market - Tier Analysis - Percentage of Revenues by Tier Level, 2023 Versus 2032
  • FIG. 13 Global Enteral Feeding Formulas Market, By Product, 2023 Vs 2032, %
  • FIG. 14 Global Enteral Feeding Formulas Market, By Stage, 2023 Vs 2032, %
  • FIG. 15 Global Enteral Feeding Formulas Market, By Application, 2023 Vs 2032, %
  • FIG. 16 Global Enteral Feeding Formulas Market, By End Use, 2023 Vs 2032, %
  • FIG. 17 U.S. Enteral Feeding Formulas Market (US$ Million), 2022 - 2032
  • FIG. 18 Canada Enteral Feeding Formulas Market (US$ Million), 2022 - 2032
  • FIG. 19 Rest of North America Enteral Feeding Formulas Market (US$ Million), 2022 - 2032
  • FIG. 20 UK Enteral Feeding Formulas Market (US$ Million), 2022 - 2032
  • FIG. 21 Germany Enteral Feeding Formulas Market (US$ Million), 2022 - 2032
  • FIG. 22 Spain Enteral Feeding Formulas Market (US$ Million), 2022 - 2032
  • FIG. 23 Italy Enteral Feeding Formulas Market (US$ Million), 2022 - 2032
  • FIG. 24 France Enteral Feeding Formulas Market (US$ Million), 2022 - 2032
  • FIG. 25 Rest of Europe Enteral Feeding Formulas Market (US$ Million), 2022 - 2032
  • FIG. 26 China Enteral Feeding Formulas Market (US$ Million), 2022 - 2032
  • FIG. 27 Japan Enteral Feeding Formulas Market (US$ Million), 2022 - 2032
  • FIG. 28 India Enteral Feeding Formulas Market (US$ Million), 2022 - 2032
  • FIG. 29 Australia Enteral Feeding Formulas Market (US$ Million), 2022 - 2032
  • FIG. 30 South Korea Enteral Feeding Formulas Market (US$ Million), 2022 - 2032
  • FIG. 31 Rest of Asia Enteral Feeding Formulas Market (US$ Million), 2022 - 2032
  • FIG. 32 Brazil Enteral Feeding Formulas Market (US$ Million), 2022 - 2032
  • FIG. 33 Mexico Enteral Feeding Formulas Market (US$ Million), 2022 - 2032
  • FIG. 34 Rest of Latin America Enteral Feeding Formulas Market (US$ Million), 2022 - 2032
  • FIG. 35 GCC Enteral Feeding Formulas Market (US$ Million), 2022 - 2032
  • FIG. 36 Africa Enteral Feeding Formulas Market (US$ Million), 2022 - 2032
  • FIG. 37 Rest of Middle East and Africa Enteral Feeding Formulas Market (US$ Million), 2022 - 2032
目次
Product Code: 140823-11-24

The enteral feeding formulas market encompasses a range of nutritional solutions administered to patients via the gastrointestinal tract when oral intake is inadequate, impossible, or unsafe. This method of feeding is used across various healthcare settings including hospitals, long-term care facilities, and home care. Enteral feeding is a vital component of clinical nutrition, especially for patients suffering from chronic diseases, those undergoing surgery, or individuals with malnutrition issues. The market for these formulas is driven by the rising prevalence of chronic diseases, advancements in formula compositions, and the increasing global elderly population. The enteral feeding formulas market is expected to grow at a CAGR of 7.2% during the forecast period of 2024 to 2032.

Drivers of the Enteral Feeding Formulas Market

Rising Incidence of Chronic Diseases and Malnutrition

The increasing prevalence of chronic diseases such as cancer, diabetes, and neurological disorders where patients often experience difficulty in maintaining adequate oral intake is a primary driver for the enteral feeding formulas market. The enhanced nutrition provided by these formulas helps manage disease symptoms, supports recovery, and improves the overall quality of life for patients. Hospitals and long-term care facilities are increasingly adopting enteral nutrition as a standard care practice for managing malnutrition and disease-related wasting, further propelling the demand for these products.

Technological Advancements in Feeding Formulas and Equipment

Significant technological advancements in the formulation and delivery of enteral feeding products have expanded their use and efficiency. The development of disease-specific formulas, which cater to the unique nutritional needs of patients with specific conditions like renal failure or pulmonary disorders, has enhanced patient outcomes and compliance with nutritional therapies. Innovations in feeding delivery systems, such as programmable pumps that ensure precise and safe feeding, have also contributed to market growth. These technological enhancements improve the palatability, absorption, and efficacy of feeding formulas, increasing their adoption across various medical and home care settings.

Aging Global Population

The global increase in the elderly population, who are more prone to chronic conditions and dysphagia (difficulty in swallowing), significantly drives the demand for enteral feeding formulas. Elderly patients often require long-term nutritional management to maintain their health and manage age-related physiological changes. The ease of use and the ability to administer these formulas at home have made enteral nutrition a preferred choice for geriatric care, supporting sustained growth in this segment of the market.

Restraint of the Enteral Feeding Formulas Market

Complications Associated with Enteral Feeding

Despite the benefits, the enteral feeding formulas market faces significant restraints due to the complications associated with tube feeding. Issues such as tube dislodgment, infections, and gastrointestinal complications like diarrhea and constipation can deter the use of enteral feeding. These complications require careful monitoring and management, adding to the overall healthcare costs and burden on providers and caregivers. The risk of aspiration and resultant pneumonia also poses a serious health risk, particularly in elderly and severely ill patients. This challenge impacts the adoption rates of enteral feeding among healthcare providers who must balance the benefits of enteral nutrition with the potential for adverse effects. The complexity of managing these risks, coupled with the need for specialized training for caregivers and healthcare professionals in tube feeding techniques, somewhat limits the market's growth potential.

Market Segmentation by Product

The enteral feeding formulas market is segmented by product into standard formulas, disease-specific formulas, elemental formulas, semi-elemental formulas, and other formulas. Disease-specific formulas are projected to exhibit the highest Compound Annual Growth Rate (CAGR) due to their targeted approach in managing specific clinical conditions such as renal disease, respiratory disease, or diabetes. These formulas are designed to meet the unique nutritional requirements and restrictions of these conditions, enhancing patient outcomes and compliance. On the other hand, standard formulas are anticipated to generate the highest revenue within the market. These formulas are broadly used due to their general application in providing balanced nutrition for patients without specific dietary restrictions or specialized nutritional needs. Standard formulas are a fundamental part of enteral nutrition across various healthcare settings, from hospitals to home care, making them a staple product in the enteral feeding industry. Their widespread use and the growing acceptance of enteral nutrition as a part of routine clinical care drive substantial revenues in this segment.

Market Segmentation by Stage

In the enteral feeding formulas market, segmentation by stage includes adults and pediatric patients. The pediatric segment is expected to experience the highest CAGR owing to the critical need for adequate nutrition in early development stages and the rising incidence of pediatric diseases and disorders that impair oral intake, such as failure to thrive, cerebral palsy, and cystic fibrosis. Pediatric formulas are specially designed to meet the nutritional needs of children, considering their growth requirements and metabolic rates. In contrast, the adult segment accounts for the highest revenue due to the larger volume of adult patients requiring enteral nutrition. This includes elderly patients with chronic illnesses or those undergoing recovery from surgery, as well as adults with disabilities or those receiving palliative care. The adult segment's dominance in revenue is supported by the increasing aging population globally and the prevalence of chronic diseases that necessitate long-term nutritional management, ensuring sustained demand for adult-specific enteral feeding formulas.

Geographic Segment in the Enteral Feeding Formulas Market

Within the enteral feeding formulas market, geographic trends reveal that North America currently leads in terms of revenue, bolstered by advanced healthcare infrastructure, high healthcare spending, and a growing prevalence of chronic diseases that require clinical nutrition solutions. Additionally, the region's stringent regulatory standards and high awareness about the benefits of enteral nutrition sustain its market dominance. Meanwhile, Asia-Pacific is expected to exhibit the highest Compound Annual Growth Rate (CAGR) from 2024 to 2032. This surge is driven by the increasing elderly population, particularly in countries like Japan and China, alongside rising healthcare expenditures and improving healthcare infrastructure. The expansion of hospitals and the increasing prevalence of diseases requiring nutritional management in these regions are also crucial factors accelerating market growth. Furthermore, government initiatives aiming to improve patient outcomes and the growing adoption of home healthcare services are amplifying the demand for enteral feeding solutions in Asia-Pacific, making it a rapidly expanding market within the global landscape.

Competitive Trends in the Enteral Feeding Formulas Market

The competitive landscape in the enteral feeding formulas market features prominent players such as Abbott Laboratories, B. Braun Melsungen AG, Baxter International, Danone S.A., Fresenius Kabi, Functional Formularies, Hormel Health Labs, Kate Farms, Medtrition, Meiji Holdings, Nestle, NutriMedical, Real Food Blends, Vegenat Healthcare, and Victus. These companies have been instrumental in shaping the market dynamics through continuous innovation and strategic initiatives. In 2022, leading companies like Nestle and Abbott Laboratories reported robust revenues driven by their diversified product portfolios and strong global distribution networks. From 2024 to 2032, these key players are expected to focus on expanding their geographic presence and enhancing product offerings to meet the specific nutritional needs of a diverse patient population. Strategic mergers and acquisitions are anticipated to be prevalent as companies aim to broaden their capabilities and access emerging markets. Furthermore, investment in research and development is expected to increase, with a focus on creating more specialized and disease-specific formulas that cater to a range of medical conditions. The development of organic and non-GMO formulas is also anticipated to gain traction, responding to consumer demand for cleaner and more transparent ingredient lists. Additionally, collaborations with healthcare providers and institutions are likely to enhance the reach and implementation of advanced nutritional solutions, ensuring these companies maintain their competitive edge in a market driven by both innovation and regulatory compliance. Through these strategies, the top companies in the enteral feeding formulas market are set to continue their dominance while fostering market growth through enhanced patient outcomes and expanded global reach.

Historical & Forecast Period

This study report represents an analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends & technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. The key data points that enable the estimation of Enteral Feeding Formulas market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users & consumption volume, price, and value.

Geographical revenues generated by countries considered in the report

Micro and macro environment factors that are currently influencing the Enteral Feeding Formulas market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top-down and bottom-up approach for validation of market estimation assures logical, methodical, and mathematical consistency of the quantitative data.

  • Market Segmentation
  • Product
    • Standard formulas
    • Disease specific formulas
    • Elemental formulas
    • Semi-elemental formulas
    • Other formulas
  • Stage
    • Adults
    • Pediatric
  • Application
    • Oncology
    • Gastrointestinal diseases
    • Neurological disorders
    • Diabetes
    • Critical care
    • Other applications
  • End Use
    • Hospitals
    • Long term care facilities
    • Home care settings
    • Nursing homes
  • Region Segment (2022-2032; US$ Million)
  • North America
  • U.S.
  • Canada
  • Rest of North America
  • UK and European Union
  • UK
  • Germany
  • Spain
  • Italy
  • France
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East and Africa
  • GCC
  • Africa
  • Rest of Middle East and Africa

Key questions answered in this report

  • What are the key micro and macro environmental factors that are impacting the growth of Enteral Feeding Formulas market?
  • What are the key investment pockets concerning product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2032.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Enteral Feeding Formulas market?
  • Which is the largest regional market for Enteral Feeding Formulas market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Enteral Feeding Formulas market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Enteral Feeding Formulas market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Enteral Feeding Formulas Market
  • 2.2. Global Enteral Feeding Formulas Market, By Product, 2023 (US$ Million)
  • 2.3. Global Enteral Feeding Formulas Market, By Stage, 2023 (US$ Million)
  • 2.4. Global Enteral Feeding Formulas Market, By Application, 2023 (US$ Million)
  • 2.5. Global Enteral Feeding Formulas Market, By End Use, 2023 (US$ Million)
  • 2.6. Global Enteral Feeding Formulas Market, By Geography, 2023 (US$ Million)
  • 2.7. Attractive Investment Proposition by Geography, 2023

3. Enteral Feeding Formulas Market: Competitive Analysis

  • 3.1. Market Positioning of Key Enteral Feeding Formulas Market Vendors
  • 3.2. Strategies Adopted by Enteral Feeding Formulas Market Vendors
  • 3.3. Key Industry Strategies

4. Enteral Feeding Formulas Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Enteral Feeding Formulas Market Value, 2022 - 2032, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis
  • 4.6. Porter's Five Force Model
    • 4.6.1. Supplier Power
    • 4.6.2. Buyer Power
    • 4.6.3. Threat Of Substitutes
    • 4.6.4. Threat Of New Entrants
    • 4.6.5. Competitive Rivalry
  • 4.7. PESTEL Analysis
    • 4.7.1. Political Landscape
    • 4.7.2. Economic Landscape
    • 4.7.3. Technology Landscape
    • 4.7.4. Legal Landscape
    • 4.7.5. Social Landscape

5. Enteral Feeding Formulas Market: By Product, 2022-2032, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2023 Versus 2032
  • 5.3. Market Segmentation
    • 5.3.1. Standard formulas
    • 5.3.2. Disease specific formulas
    • 5.3.3. Elemental formulas
    • 5.3.4. Semi-elemental formulas
    • 5.3.5. Other formulas

6. Enteral Feeding Formulas Market: By Stage, 2022-2032, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2023 Versus 2032
  • 6.3. Market Segmentation
    • 6.3.1. Adults
    • 6.3.2. Pediatric

7. Enteral Feeding Formulas Market: By Application, 2022-2032, USD (Million)

  • 7.1. Market Overview
  • 7.2. Growth & Revenue Analysis: 2023 Versus 2032
  • 7.3. Market Segmentation
    • 7.3.1. Oncology
    • 7.3.2. Gastrointestinal diseases
    • 7.3.3. Neurological disorders
    • 7.3.4. Diabetes
    • 7.3.5. Critical care
    • 7.3.6. Other applications

8. Enteral Feeding Formulas Market: By End Use, 2022-2032, USD (Million)

  • 8.1. Market Overview
  • 8.2. Growth & Revenue Analysis: 2023 Versus 2032
  • 8.3. Market Segmentation
    • 8.3.1. Hospitals
    • 8.3.2. Long term care facilities
    • 8.3.3. Home care settings
    • 8.3.4. Nursing homes

9. North America Enteral Feeding Formulas Market, 2022-2032, USD (Million)

  • 9.1. Market Overview
  • 9.2. Enteral Feeding Formulas Market: By Product, 2022-2032, USD (Million)
  • 9.3. Enteral Feeding Formulas Market: By Stage, 2022-2032, USD (Million)
  • 9.4. Enteral Feeding Formulas Market: By Application, 2022-2032, USD (Million)
  • 9.5. Enteral Feeding Formulas Market: By End Use, 2022-2032, USD (Million)
  • 9.6.Enteral Feeding Formulas Market: By Region, 2022-2032, USD (Million)
    • 9.6.1.North America
      • 9.6.1.1. U.S.
        • 9.6.1.1.1. Enteral Feeding Formulas Market: By Product, 2022-2032, USD (Million)
        • 9.6.1.1.2. Enteral Feeding Formulas Market: By Stage, 2022-2032, USD (Million)
        • 9.6.1.1.3. Enteral Feeding Formulas Market: By Application, 2022-2032, USD (Million)
        • 9.6.1.1.4. Enteral Feeding Formulas Market: By End Use, 2022-2032, USD (Million)
      • 9.6.1.2. Canada
        • 9.6.1.2.1. Enteral Feeding Formulas Market: By Product, 2022-2032, USD (Million)
        • 9.6.1.2.2. Enteral Feeding Formulas Market: By Stage, 2022-2032, USD (Million)
        • 9.6.1.2.3. Enteral Feeding Formulas Market: By Application, 2022-2032, USD (Million)
        • 9.6.1.2.4. Enteral Feeding Formulas Market: By End Use, 2022-2032, USD (Million)
      • 9.6.1.3. Rest of North America
        • 9.6.1.3.1. Enteral Feeding Formulas Market: By Product, 2022-2032, USD (Million)
        • 9.6.1.3.2. Enteral Feeding Formulas Market: By Stage, 2022-2032, USD (Million)
        • 9.6.1.3.3. Enteral Feeding Formulas Market: By Application, 2022-2032, USD (Million)
        • 9.6.1.3.4. Enteral Feeding Formulas Market: By End Use, 2022-2032, USD (Million)

10. UK and European Union Enteral Feeding Formulas Market, 2022-2032, USD (Million)

  • 10.1. Market Overview
  • 10.2. Enteral Feeding Formulas Market: By Product, 2022-2032, USD (Million)
  • 10.3. Enteral Feeding Formulas Market: By Stage, 2022-2032, USD (Million)
  • 10.4. Enteral Feeding Formulas Market: By Application, 2022-2032, USD (Million)
  • 10.5. Enteral Feeding Formulas Market: By End Use, 2022-2032, USD (Million)
  • 10.6.Enteral Feeding Formulas Market: By Region, 2022-2032, USD (Million)
    • 10.6.1.UK and European Union
      • 10.6.1.1. UK
        • 10.6.1.1.1. Enteral Feeding Formulas Market: By Product, 2022-2032, USD (Million)
        • 10.6.1.1.2. Enteral Feeding Formulas Market: By Stage, 2022-2032, USD (Million)
        • 10.6.1.1.3. Enteral Feeding Formulas Market: By Application, 2022-2032, USD (Million)
        • 10.6.1.1.4. Enteral Feeding Formulas Market: By End Use, 2022-2032, USD (Million)
      • 10.6.1.2. Germany
        • 10.6.1.2.1. Enteral Feeding Formulas Market: By Product, 2022-2032, USD (Million)
        • 10.6.1.2.2. Enteral Feeding Formulas Market: By Stage, 2022-2032, USD (Million)
        • 10.6.1.2.3. Enteral Feeding Formulas Market: By Application, 2022-2032, USD (Million)
        • 10.6.1.2.4. Enteral Feeding Formulas Market: By End Use, 2022-2032, USD (Million)
      • 10.6.1.3. Spain
        • 10.6.1.3.1. Enteral Feeding Formulas Market: By Product, 2022-2032, USD (Million)
        • 10.6.1.3.2. Enteral Feeding Formulas Market: By Stage, 2022-2032, USD (Million)
        • 10.6.1.3.3. Enteral Feeding Formulas Market: By Application, 2022-2032, USD (Million)
        • 10.6.1.3.4. Enteral Feeding Formulas Market: By End Use, 2022-2032, USD (Million)
      • 10.6.1.4. Italy
        • 10.6.1.4.1. Enteral Feeding Formulas Market: By Product, 2022-2032, USD (Million)
        • 10.6.1.4.2. Enteral Feeding Formulas Market: By Stage, 2022-2032, USD (Million)
        • 10.6.1.4.3. Enteral Feeding Formulas Market: By Application, 2022-2032, USD (Million)
        • 10.6.1.4.4. Enteral Feeding Formulas Market: By End Use, 2022-2032, USD (Million)
      • 10.6.1.5. France
        • 10.6.1.5.1. Enteral Feeding Formulas Market: By Product, 2022-2032, USD (Million)
        • 10.6.1.5.2. Enteral Feeding Formulas Market: By Stage, 2022-2032, USD (Million)
        • 10.6.1.5.3. Enteral Feeding Formulas Market: By Application, 2022-2032, USD (Million)
        • 10.6.1.5.4. Enteral Feeding Formulas Market: By End Use, 2022-2032, USD (Million)
      • 10.6.1.6. Rest of Europe
        • 10.6.1.6.1. Enteral Feeding Formulas Market: By Product, 2022-2032, USD (Million)
        • 10.6.1.6.2. Enteral Feeding Formulas Market: By Stage, 2022-2032, USD (Million)
        • 10.6.1.6.3. Enteral Feeding Formulas Market: By Application, 2022-2032, USD (Million)
        • 10.6.1.6.4. Enteral Feeding Formulas Market: By End Use, 2022-2032, USD (Million)

11. Asia Pacific Enteral Feeding Formulas Market, 2022-2032, USD (Million)

  • 11.1. Market Overview
  • 11.2. Enteral Feeding Formulas Market: By Product, 2022-2032, USD (Million)
  • 11.3. Enteral Feeding Formulas Market: By Stage, 2022-2032, USD (Million)
  • 11.4. Enteral Feeding Formulas Market: By Application, 2022-2032, USD (Million)
  • 11.5. Enteral Feeding Formulas Market: By End Use, 2022-2032, USD (Million)
  • 11.6.Enteral Feeding Formulas Market: By Region, 2022-2032, USD (Million)
    • 11.6.1.Asia Pacific
      • 11.6.1.1. China
        • 11.6.1.1.1. Enteral Feeding Formulas Market: By Product, 2022-2032, USD (Million)
        • 11.6.1.1.2. Enteral Feeding Formulas Market: By Stage, 2022-2032, USD (Million)
        • 11.6.1.1.3. Enteral Feeding Formulas Market: By Application, 2022-2032, USD (Million)
        • 11.6.1.1.4. Enteral Feeding Formulas Market: By End Use, 2022-2032, USD (Million)
      • 11.6.1.2. Japan
        • 11.6.1.2.1. Enteral Feeding Formulas Market: By Product, 2022-2032, USD (Million)
        • 11.6.1.2.2. Enteral Feeding Formulas Market: By Stage, 2022-2032, USD (Million)
        • 11.6.1.2.3. Enteral Feeding Formulas Market: By Application, 2022-2032, USD (Million)
        • 11.6.1.2.4. Enteral Feeding Formulas Market: By End Use, 2022-2032, USD (Million)
      • 11.6.1.3. India
        • 11.6.1.3.1. Enteral Feeding Formulas Market: By Product, 2022-2032, USD (Million)
        • 11.6.1.3.2. Enteral Feeding Formulas Market: By Stage, 2022-2032, USD (Million)
        • 11.6.1.3.3. Enteral Feeding Formulas Market: By Application, 2022-2032, USD (Million)
        • 11.6.1.3.4. Enteral Feeding Formulas Market: By End Use, 2022-2032, USD (Million)
      • 11.6.1.4. Australia
        • 11.6.1.4.1. Enteral Feeding Formulas Market: By Product, 2022-2032, USD (Million)
        • 11.6.1.4.2. Enteral Feeding Formulas Market: By Stage, 2022-2032, USD (Million)
        • 11.6.1.4.3. Enteral Feeding Formulas Market: By Application, 2022-2032, USD (Million)
        • 11.6.1.4.4. Enteral Feeding Formulas Market: By End Use, 2022-2032, USD (Million)
      • 11.6.1.5. South Korea
        • 11.6.1.5.1. Enteral Feeding Formulas Market: By Product, 2022-2032, USD (Million)
        • 11.6.1.5.2. Enteral Feeding Formulas Market: By Stage, 2022-2032, USD (Million)
        • 11.6.1.5.3. Enteral Feeding Formulas Market: By Application, 2022-2032, USD (Million)
        • 11.6.1.5.4. Enteral Feeding Formulas Market: By End Use, 2022-2032, USD (Million)
      • 11.6.1.6. Rest of Asia Pacific
        • 11.6.1.6.1. Enteral Feeding Formulas Market: By Product, 2022-2032, USD (Million)
        • 11.6.1.6.2. Enteral Feeding Formulas Market: By Stage, 2022-2032, USD (Million)
        • 11.6.1.6.3. Enteral Feeding Formulas Market: By Application, 2022-2032, USD (Million)
        • 11.6.1.6.4. Enteral Feeding Formulas Market: By End Use, 2022-2032, USD (Million)

12. Latin America Enteral Feeding Formulas Market, 2022-2032, USD (Million)

  • 12.1. Market Overview
  • 12.2. Enteral Feeding Formulas Market: By Product, 2022-2032, USD (Million)
  • 12.3. Enteral Feeding Formulas Market: By Stage, 2022-2032, USD (Million)
  • 12.4. Enteral Feeding Formulas Market: By Application, 2022-2032, USD (Million)
  • 12.5. Enteral Feeding Formulas Market: By End Use, 2022-2032, USD (Million)
  • 12.6.Enteral Feeding Formulas Market: By Region, 2022-2032, USD (Million)
    • 12.6.1.Latin America
      • 12.6.1.1. Brazil
        • 12.6.1.1.1. Enteral Feeding Formulas Market: By Product, 2022-2032, USD (Million)
        • 12.6.1.1.2. Enteral Feeding Formulas Market: By Stage, 2022-2032, USD (Million)
        • 12.6.1.1.3. Enteral Feeding Formulas Market: By Application, 2022-2032, USD (Million)
        • 12.6.1.1.4. Enteral Feeding Formulas Market: By End Use, 2022-2032, USD (Million)
      • 12.6.1.2. Mexico
        • 12.6.1.2.1. Enteral Feeding Formulas Market: By Product, 2022-2032, USD (Million)
        • 12.6.1.2.2. Enteral Feeding Formulas Market: By Stage, 2022-2032, USD (Million)
        • 12.6.1.2.3. Enteral Feeding Formulas Market: By Application, 2022-2032, USD (Million)
        • 12.6.1.2.4. Enteral Feeding Formulas Market: By End Use, 2022-2032, USD (Million)
      • 12.6.1.3. Rest of Latin America
        • 12.6.1.3.1. Enteral Feeding Formulas Market: By Product, 2022-2032, USD (Million)
        • 12.6.1.3.2. Enteral Feeding Formulas Market: By Stage, 2022-2032, USD (Million)
        • 12.6.1.3.3. Enteral Feeding Formulas Market: By Application, 2022-2032, USD (Million)
        • 12.6.1.3.4. Enteral Feeding Formulas Market: By End Use, 2022-2032, USD (Million)

13. Middle East and Africa Enteral Feeding Formulas Market, 2022-2032, USD (Million)

  • 13.1. Market Overview
  • 13.2. Enteral Feeding Formulas Market: By Product, 2022-2032, USD (Million)
  • 13.3. Enteral Feeding Formulas Market: By Stage, 2022-2032, USD (Million)
  • 13.4. Enteral Feeding Formulas Market: By Application, 2022-2032, USD (Million)
  • 13.5. Enteral Feeding Formulas Market: By End Use, 2022-2032, USD (Million)
  • 13.6.Enteral Feeding Formulas Market: By Region, 2022-2032, USD (Million)
    • 13.6.1.Middle East and Africa
      • 13.6.1.1. GCC
        • 13.6.1.1.1. Enteral Feeding Formulas Market: By Product, 2022-2032, USD (Million)
        • 13.6.1.1.2. Enteral Feeding Formulas Market: By Stage, 2022-2032, USD (Million)
        • 13.6.1.1.3. Enteral Feeding Formulas Market: By Application, 2022-2032, USD (Million)
        • 13.6.1.1.4. Enteral Feeding Formulas Market: By End Use, 2022-2032, USD (Million)
      • 13.6.1.2. Africa
        • 13.6.1.2.1. Enteral Feeding Formulas Market: By Product, 2022-2032, USD (Million)
        • 13.6.1.2.2. Enteral Feeding Formulas Market: By Stage, 2022-2032, USD (Million)
        • 13.6.1.2.3. Enteral Feeding Formulas Market: By Application, 2022-2032, USD (Million)
        • 13.6.1.2.4. Enteral Feeding Formulas Market: By End Use, 2022-2032, USD (Million)
      • 13.6.1.3. Rest of Middle East and Africa
        • 13.6.1.3.1. Enteral Feeding Formulas Market: By Product, 2022-2032, USD (Million)
        • 13.6.1.3.2. Enteral Feeding Formulas Market: By Stage, 2022-2032, USD (Million)
        • 13.6.1.3.3. Enteral Feeding Formulas Market: By Application, 2022-2032, USD (Million)
        • 13.6.1.3.4. Enteral Feeding Formulas Market: By End Use, 2022-2032, USD (Million)

14. Company Profile

  • 14.1. Abbott Laboratories
    • 14.1.1. Company Overview
    • 14.1.2. Financial Performance
    • 14.1.3. Product Portfolio
    • 14.1.4. Strategic Initiatives
  • 14.2. B. Braun Melsungen AG
    • 14.2.1. Company Overview
    • 14.2.2. Financial Performance
    • 14.2.3. Product Portfolio
    • 14.2.4. Strategic Initiatives
  • 14.3. Baxter International
    • 14.3.1. Company Overview
    • 14.3.2. Financial Performance
    • 14.3.3. Product Portfolio
    • 14.3.4. Strategic Initiatives
  • 14.4. Danone S.A.
    • 14.4.1. Company Overview
    • 14.4.2. Financial Performance
    • 14.4.3. Product Portfolio
    • 14.4.4. Strategic Initiatives
  • 14.5. Fresenius Kabi
    • 14.5.1. Company Overview
    • 14.5.2. Financial Performance
    • 14.5.3. Product Portfolio
    • 14.5.4. Strategic Initiatives
  • 14.6. Functional Formularies
    • 14.6.1. Company Overview
    • 14.6.2. Financial Performance
    • 14.6.3. Product Portfolio
    • 14.6.4. Strategic Initiatives
  • 14.7. Hormel Health Labs
    • 14.7.1. Company Overview
    • 14.7.2. Financial Performance
    • 14.7.3. Product Portfolio
    • 14.7.4. Strategic Initiatives
  • 14.8. Kate Farms
    • 14.8.1. Company Overview
    • 14.8.2. Financial Performance
    • 14.8.3. Product Portfolio
    • 14.8.4. Strategic Initiatives
  • 14.9. Medtrition
    • 14.9.1. Company Overview
    • 14.9.2. Financial Performance
    • 14.9.3. Product Portfolio
    • 14.9.4. Strategic Initiatives
  • 14.10. Meiji Holdings
    • 14.10.1. Company Overview
    • 14.10.2. Financial Performance
    • 14.10.3. Product Portfolio
    • 14.10.4. Strategic Initiatives
  • 14.11. Nestle
    • 14.11.1. Company Overview
    • 14.11.2. Financial Performance
    • 14.11.3. Product Portfolio
    • 14.11.4. Strategic Initiatives
  • 14.12. NutriMedical
    • 14.12.1. Company Overview
    • 14.12.2. Financial Performance
    • 14.12.3. Product Portfolio
    • 14.12.4. Strategic Initiatives
  • 14.13. Real Food Blends
    • 14.13.1. Company Overview
    • 14.13.2. Financial Performance
    • 14.13.3. Product Portfolio
    • 14.13.4. Strategic Initiatives
  • 14.14. Vegenat Healthcare
    • 14.14.1. Company Overview
    • 14.14.2. Financial Performance
    • 14.14.3. Product Portfolio
    • 14.14.4. Strategic Initiatives
  • 14.15. Victus
    • 14.15.1. Company Overview
    • 14.15.2. Financial Performance
    • 14.15.3. Product Portfolio
    • 14.15.4. Strategic Initiatives